Non-Invasive Monitoring Systems Extends Insider Debt and Adds Financing

Detailed price information for Non-Invasive Monitoring Systems Inc (NIMU) from The Globe and Mail including charting and trades.

Compremium Receives FDA Breakthrough Device Designation for Non-Invasive Central Venous Pressure Measurement System and has also joined FDA’s TAP Progr…

Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ...
Business Insider

North America Hemodynamic Monitoring Industry, 2025 - Minimally Invasive Monitoring Systems to Hold Significant Market Share

Dublin, July 24, 2020 (GLOBE NEWSWIRE) -- The "North America Hemodynamic Monitoring Market - Growth, Trends, and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering. The ...
Hosted on MSN

PreEvnt’s Isaac non-invasive glucose alert system enters human trials

For many people living with diabetes or prediabetes, the daily routine of managing blood sugar is defined by needles and finger pricks. However, at CES 2026, a health tech company is presenting a ...
MarketWatch

SeeMedX Files 510(k) with FDA for Innovative Cardiac Monitoring System to Transform Heart Failure Care

Transformative, non-invasive technology provides real-time insights into cardiac performance and fluid status, enabling clinicians to optimize heart failure treatment earlier than ever and improve ...
News-Medical.Net

What Is Bio-Monitoring? The Role of Spectroscopy in Real-Time Analysis

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Nature

Non-Invasive Blood Pressure Monitoring and Hemodynamic Assessment

Non-invasive blood pressure monitoring has undergone significant advancements in recent years, moving beyond conventional intermittent oscillometric methods. The development of continuous monitoring ...
Android

PreEvnt’s isaac Non-Invasive Glucose Alert System Enters Human Trials

PreEvnt’s isaac system is getting closer to its targeted Q4 2026 launch. It has gone from a concept prototype to active human clinical trials. The device uses VOC-sensing technology to check glucose ...